Ignite Creation Date:
2025-12-24 @ 6:58 PM
Ignite Modification Date:
2026-01-05 @ 6:08 PM
Study NCT ID:
NCT05886257
Status:
WITHDRAWN
Last Update Posted:
2023-06-02
First Post:
2022-12-06
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Candonilimab Plus Bevacizumab for Patients With Advanced HCC Who Progressed on A+T
Sponsor:
Shi Ming
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
S104
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None